This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and anxiolytics. Its structure allows for modifications that can enhance binding affinity to specific receptors, making it a versatile building block in medicinal chemistry. Additionally, it is explored in research for potential applications in treating neurodegenerative diseases due to its ability to cross the blood-brain barrier. Its methoxy and cyclopropyl groups contribute to its stability and reactivity, which are crucial for creating effective therapeutic agents.